XiFin Secures Growth Capital Investment and Appoints Health IT Innovator Jeff Margolis to Its Board

Strategic Insights -

XiFin, a leader in revenue cycle management (RCM) and billing solutions enhanced with embedded artificial intelligence (AI), has announced a new growth capital investment and the addition of health IT innovator and futurist Jeff Margolis to its Board of Directors. This investment builds on XiFin's 19% year-over-year growth, driven by client adoption of its flagship next-gen platform, XiFin Empower. The platform empowers healthcare organizations to navigate the complex healthcare environment with AI-enabled revenue cycle and workflow solutions.

Key Takeaways:

  • XiFin has secured a growth capital investment from Goldman Sachs' External Investing Group, with continued support from majority investor Avista Healthcare Partners and other institutional backers.
  • The investment underscores growing demand for XiFin's award-winning infrastructure that unifies automation, AI, and data analytics to modernize healthcare operations.
  • XiFin Empower, the company's flagship platform, drives operational efficiency, productivity, and workflow automation across revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement.
  • The platform enables organizations to simplify revenue cycle workflows, improve financial performance, and enhance patient and provider experiences.
  • Jeff Margolis, a healthcare IT veteran with over 35 years of experience in AI-driven innovation, has joined XiFin's Board of Directors.
  • Margolis is a former founder of TriZetto, the first vertical SaaS platform for benefit plan administration serving over 130 million people.
  • He currently advises Blackstone and serves on multiple healthcare and technology boards.

Statistics:

  • XiFin has achieved 19% year-over-year growth.
  • The company's flagship platform, XiFin Empower, drives operational efficiency, productivity, and workflow automation across revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement.
  • XiFin's investment round enables the company to continue solving complex healthcare challenges and delivering best-in-class technology to more partners.
  • Jeff Margolis has over 35 years of experience in AI-driven innovation.

Sources:

  • XiFin
  • Goldman Sachs' External Investing Group
  • Avista Healthcare Partners